Aviva has appointed Dr Helen Hartley as associate medical director within its private medical insurance (PMI) clinical team.
Hartley (pictured) joins from Bupa where she spent nearly four years as a UK insurance medical director.
She will report to Aviva medical director Dr Suba M and completes a clinical team including medical directors Dr Doug Wright and Dr Suba M and associate medical director Dr Jochem Caris, the insurer said.
Aviva added Hartley will use her understanding of the clinical, ethical, and regulatory aspects of private healthcare in leading an expanded clinical governance team, supporting its drive towards value-based healthcare funding.
She will also be involved in applying her clinical knowledge to other activities across Aviva’s product design and delivery.
She has close working relationships with The Private Healthcare Information Network (PHIN), participating in its cross-sector PROMs Working Group and the Association of British Insurers, chairing its pan-PMI patient safety working group.
Dr Suba M welcomed Hartley to lead the growing clinical risk and governance team.
“As we evolve our business to meet the rapid growth in the private healthcare sector, emerging trends of health tech, consumerisation of health and focus on prevention, it is critical that we continue to keep patient safety and good customer outcomes at the forefront,“ she said.
“Helen’s breadth and depth of expertise in the regulatory landscape and insurance industry augments and accelerates Aviva’s strategy to fund effective, efficient, equitable and enduring healthcare that deliver positive health outcomes.”
Dr Hartley added: “It’s a great opportunity to work at Aviva, as its focus and achievements in value-based healthcare contracting and strong governance oversight align with my mission to see that insurance customers achieve good patient outcomes and experience high-quality, safe, cost-efficient healthcare.
“I am excited to join Aviva’s clinical team to support the strategy on value-based healthcare and ESG, and to lead Aviva’s clinical governance team to achieve strong quality assurance regarding Aviva’s value proposition.”